AR067348A1 - Un procedimiento para preparar acido 2- (3-(6-(2-(2,4- diclorofenil)- etrilamino )-2- metoxipirimidin -4-il)- fenil)-2- metil - proionico - Google Patents
Un procedimiento para preparar acido 2- (3-(6-(2-(2,4- diclorofenil)- etrilamino )-2- metoxipirimidin -4-il)- fenil)-2- metil - proionicoInfo
- Publication number
- AR067348A1 AR067348A1 ARP080102795A ARP080102795A AR067348A1 AR 067348 A1 AR067348 A1 AR 067348A1 AR P080102795 A ARP080102795 A AR P080102795A AR P080102795 A ARP080102795 A AR P080102795A AR 067348 A1 AR067348 A1 AR 067348A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenyl
- methyl
- metoxipirimidin
- etrilamino
- diclorophenil
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- LQNOAOPATMVLRQ-UHFFFAOYSA-N 2-[3-(6-chloro-2-oxo-1h-pyrimidin-4-yl)phenyl]-2-methylpropanoic acid Chemical compound OC(=O)C(C)(C)C1=CC=CC(C=2N=C(O)N=C(Cl)C=2)=C1 LQNOAOPATMVLRQ-UHFFFAOYSA-N 0.000 abstract 2
- -1 3- {6- [2- (2,4-dichloro-phenyl) -ethylamino] -2-methoxy-pyrimidin-4-yl} -phenyl Chemical group 0.000 abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- VHJKDOLGYMULOP-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)ethanamine Chemical compound NCCC1=CC=C(Cl)C=C1Cl VHJKDOLGYMULOP-UHFFFAOYSA-N 0.000 abstract 1
- VASYXSHADMRQTM-UHFFFAOYSA-N 2-(3-boronophenyl)-2-methylpropanoic acid Chemical compound OC(=O)C(C)(C)C1=CC=CC(B(O)O)=C1 VASYXSHADMRQTM-UHFFFAOYSA-N 0.000 abstract 1
- WDELVDLDINRUQF-UHFFFAOYSA-N 4,6-dichloro-2-methoxypyrimidine Chemical compound COC1=NC(Cl)=CC(Cl)=N1 WDELVDLDINRUQF-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94725607P | 2007-06-29 | 2007-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR067348A1 true AR067348A1 (es) | 2009-10-07 |
Family
ID=40226759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080102795A AR067348A1 (es) | 2007-06-29 | 2008-06-27 | Un procedimiento para preparar acido 2- (3-(6-(2-(2,4- diclorofenil)- etrilamino )-2- metoxipirimidin -4-il)- fenil)-2- metil - proionico |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100184979A1 (enExample) |
| EP (1) | EP2170837B1 (enExample) |
| JP (1) | JP2010532366A (enExample) |
| AR (1) | AR067348A1 (enExample) |
| AT (1) | ATE531699T1 (enExample) |
| CL (1) | CL2008001913A1 (enExample) |
| PA (1) | PA8786301A1 (enExample) |
| PE (1) | PE20090428A1 (enExample) |
| TW (1) | TW200922927A (enExample) |
| UY (1) | UY31192A1 (enExample) |
| WO (1) | WO2009006086A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5833626B2 (ja) * | 2010-03-23 | 2015-12-16 | サイノファーム タイワン リミテッド | ラパチニブの調製プロセス及び中間体 |
| CN104592137B (zh) * | 2014-11-04 | 2016-09-14 | 江苏大学 | 2,2’,2”-[1,3,5-三嗪-2,4,6-三巯基]三丙酸及其合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN2005000795A (es) | 2004-10-15 | 2010-08-19 | Aventis Pharma Inc | Pirimidinas como antagonistas del receptor de prostaglandina d2 |
| GT200600457A (es) * | 2005-10-13 | 2007-04-27 | Aventis Pharma Inc | Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2 |
| AR074776A1 (es) * | 2008-12-18 | 2011-02-09 | Sanofi Aventis | Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente |
-
2008
- 2008-06-24 JP JP2010515021A patent/JP2010532366A/ja not_active Abandoned
- 2008-06-24 WO PCT/US2008/067963 patent/WO2009006086A2/en not_active Ceased
- 2008-06-24 EP EP08771774A patent/EP2170837B1/en not_active Not-in-force
- 2008-06-24 AT AT08771774T patent/ATE531699T1/de active
- 2008-06-27 PE PE2008001109A patent/PE20090428A1/es not_active Application Discontinuation
- 2008-06-27 PA PA20088786301A patent/PA8786301A1/es unknown
- 2008-06-27 UY UY31192A patent/UY31192A1/es not_active Application Discontinuation
- 2008-06-27 AR ARP080102795A patent/AR067348A1/es not_active Application Discontinuation
- 2008-06-27 CL CL2008001913A patent/CL2008001913A1/es unknown
- 2008-06-27 TW TW097124002A patent/TW200922927A/zh unknown
-
2009
- 2009-12-16 US US12/639,507 patent/US20100184979A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PA8786301A1 (es) | 2009-01-23 |
| EP2170837B1 (en) | 2011-11-02 |
| JP2010532366A (ja) | 2010-10-07 |
| EP2170837A2 (en) | 2010-04-07 |
| US20100184979A1 (en) | 2010-07-22 |
| TW200922927A (en) | 2009-06-01 |
| WO2009006086A3 (en) | 2009-03-12 |
| ATE531699T1 (de) | 2011-11-15 |
| UY31192A1 (es) | 2009-01-30 |
| PE20090428A1 (es) | 2009-05-04 |
| WO2009006086A2 (en) | 2009-01-08 |
| CL2008001913A1 (es) | 2009-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000346A1 (es) | Proceso para preparar compuestos intermediarios en la preparación de pirazolil pirrol pirimidinas. | |
| PE20100715A1 (es) | Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina | |
| CN101945861B (zh) | 一种苯甲酰胺类化合物的制备方法 | |
| DK2057126T3 (da) | Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater | |
| UY28759A1 (es) | Nuevo proceso para la sintesis de la ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable | |
| UA101712C2 (ru) | Способ производства производных замещенной метоксиметилпиридин-2,3-дикарбоновой кислоты | |
| UY30682A1 (es) | Nueva difenilazetidinona sustituida con acido piperazina-1-sulfonico con propiedades farmacologicas mejoradas | |
| CL2008003185A1 (es) | Procedimiento para la preparacion de medetomidina que considera el acoplamiento entre un siliimidazol y un derivado de alcohol bencilico. | |
| DK2210884T3 (da) | Fremgangsmåde til fremstilling af 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propionsyre eller salte deraf | |
| BR112013021201A2 (pt) | método de preparação de carfentrazona-etílica | |
| CY1119452T1 (el) | Μια μεθοδος παρασκευης 2-αιθοξυ-1-(2'-((υδροξυamino) ιμινομεθυλο) διφαινυλ-4-υλο) μεθυλο)-1η- βενζο (d) ιμιδαζολο-7-καρβοξυλικο οξυ και τους εστερες αυτου | |
| AR089221A1 (es) | Disales de acido malonico y metodo para preparar diahaluros de malonilo | |
| EP2072503A3 (en) | Process for the preparation of bosentan | |
| AR088358A1 (es) | Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos | |
| AR067348A1 (es) | Un procedimiento para preparar acido 2- (3-(6-(2-(2,4- diclorofenil)- etrilamino )-2- metoxipirimidin -4-il)- fenil)-2- metil - proionico | |
| MX2009002258A (es) | Procedimiento para producir 1-(3,4-diclorobencil)-5-octilbiguanida o una sal de la misma. | |
| WO2007004237A3 (en) | A process for the preparation of montelukast | |
| WO2010036048A3 (ko) | 몬테루카스트 나트륨염의 제조방법 | |
| TH100708B (th) | กระบวนการใหม่สำหรับการเตรียม 2-(3-{6-[2-(2,4-ไดคลอโรเฟนิล)-เอธิลอะมิโน]-2-เมธอกซีไพริมิดิน-4-อิล}-เฟนิล)-2-เมธิลโพรไพโอนิค แอซิด | |
| BR112012019620A2 (pt) | Processo para preparar voriconazol usando novos intermediários | |
| UA89218C2 (ru) | Способ получения галогенбензолов (варианты) | |
| WO2009006066A3 (en) | Process for the preparation of benzimidazol thienylamine compounds and intermediates thereof | |
| DE602004004810D1 (de) | Herstellungsverfahren für optisch reine 2-(4-hydroxyphenoxy)-propionsäureverbindungen | |
| DE602006002738D1 (de) | Verbessertes Verfahren zur Herstellung von Moxonidine | |
| ATE551316T1 (de) | Verfahren zur herstellung von 6-ä3-(1-adamantyl)- 4-methoxyphenylü-2-naphtoesäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |